Vélayoudom-Céphise F-L, Vantyghem M-C, Wémeau J-L
Service d'endocrinologie et métabolisme, Clinique Marc Linquette, CHRU de Lille (59). flvelayoudom@ tiscali.fr
Presse Med. 2005 Dec 17;34(22 Pt 1):1720-6. doi: 10.1016/s0755-4982(05)84260-5.
Hereditary hypophosphatemic rickets groups together X-linked hypophosphatemic rickets (XLH), autosomal dominant hypophosphatemic rickets (ADHR) and hereditary hypophosphatemic rickets with hypercalciuria (HHRH, autosomal recessive). Clinical and biological characteristics and treatment depend on specific etiology. Mutations causing hereditary hypophosphatemic rickets involve PHEX located on Xp11.22 for XLH and FGF-23 located on 12p13 for ADHR. The gene involved in HHRH remains unknown: candidates may encode proteins that modulate phosphate transporter expression or activity. Others forms of rickets must be ruled out: acquired hypophosphatemia due to oncogenic osteomalacia, X-linked recessive hypophosphatemic rickets or Dent's disease, and hereditary 1, 25-dihydroxyvitamin D-resistant rickets with a defect either in the 1-alpha-hydroxylase gene (pseudo-vitamin D deficiency rickets, PDDR) or in the vitamin D receptor (hereditary vitamin D-resistant rickets, HVDRR).
遗传性低磷性佝偻病包括X连锁低磷性佝偻病(XLH)、常染色体显性低磷性佝偻病(ADHR)和伴高钙尿症的遗传性低磷性佝偻病(HHRH,常染色体隐性)。临床和生物学特征及治疗取决于具体病因。导致遗传性低磷性佝偻病的突变涉及XLH的位于Xp11.22的PHEX基因以及ADHR的位于12p13的FGF - 23基因。HHRH所涉及的基因尚不清楚:候选基因可能编码调节磷酸盐转运蛋白表达或活性的蛋白质。必须排除其他形式的佝偻病:因肿瘤性骨软化症导致的获得性低磷血症、X连锁隐性低磷性佝偻病或丹特病,以及1,25 - 二羟维生素D抵抗性佝偻病,后者在1 - α - 羟化酶基因(假性维生素D缺乏性佝偻病,PDDR)或维生素D受体(遗传性维生素D抵抗性佝偻病,HVDRR)方面存在缺陷。